Journal of Commercial Biotechnology logo Palgrave Macmillan logo

Publisher: Palgrave Macmillan

Volume 12, Number 1, 1 October 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial: De-risking novel therapeutic development - time to stop blaming the molecule?
pp. 5-7(3)
Author: Shohet, Simon

The European biotech sector: Could it achieve more?
pp. 10-19(10)
Author: Fazeli, Sam

What to do when your technology is good but a licence is terminated
pp. 22-28(7)
Authors: Cox, Manon; Adams, Dan

Future employment in biotechnology in Germany
pp. 29-39(11)
Author: Menrad, Klaus

Human Tissue Act 2004: The age of consent arrives in the UK
pp. 40-44(5)
Authors: Johnson, Gillian; Wilson, Alex

Rethinking innovation in pharmaceutical R&D
pp. 45-49(5)
Authors: Baker, Ann; Gill, Jasween

Managing innovation in the pharmaceutical industry
pp. 50-57(8)
Authors: Schmid, Esther F; Smith, Dennis A

Taking stock in biotechnology futures
pp. 58-60(3)
Author: Jacobs, John L

Biotechnology in India: Emerging opportunities
pp. 61-66(6)
Author: Parmar, Himanshu

Marketspace: Leading therapeutic recombinant protein sales forecast and analysis to 2010
pp. 69-73(5)
Authors: Belsey, Mark J; Pavlou, Alex K

Legal and regulatory update
pp. 75-82(8)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A